These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6456421)
1. [Injectable contraceptive, DMPA, serum HDL cholesterol and heart infarct]. Kremer J; de Bruijn HW; Hindriks FR Ned Tijdschr Geneeskd; 1981 Aug; 125(35):1418-21. PubMed ID: 6456421 [TBL] [Abstract][Full Text] [Related]
2. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids. Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383 [TBL] [Abstract][Full Text] [Related]
3. Serum high density lipoprotein cholesterol levels in women using a contraceptive injection of depot-medroxyprogesterone acetate. Kremer J; de Bruijn HW; Hindriks FR Contraception; 1980 Oct; 22(4):359-67. PubMed ID: 7449384 [TBL] [Abstract][Full Text] [Related]
4. Depo Provera. Position paper on clinical use, effectiveness and side effects. Bigrigg A; Evans M; Gbolade B; Newton J; Pollard L; Szarewski A; Thomas C; Walling M Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658 [TBL] [Abstract][Full Text] [Related]
6. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results. Grossman RA; Asawasena W; Chalpati S; Taewtong D; Tovanabutra S Bull World Health Organ; 1979; 57(5):829-37. PubMed ID: 161523 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of injectable contraceptive users in a low-income population in Texas. Sangi-Haghpeykar H; Poindexter AN; Moseley DC; Bateman L; Reid ED Fam Plann Perspect; 1995; 27(5):208-11, 225. PubMed ID: 9104608 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism. Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626 [TBL] [Abstract][Full Text] [Related]
10. Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. Kaunitz AM Int J Fertil Womens Med; 1998; 43(2):73-83. PubMed ID: 9609206 [TBL] [Abstract][Full Text] [Related]
11. Long-acting injectable contraception with depot medroxyprogesterone acetate. Kaunitz AM Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1543-9. PubMed ID: 8178904 [TBL] [Abstract][Full Text] [Related]
12. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Polaneczky M; Guarnaccia M; Alon J; Wiley J Fam Plann Perspect; 1996; 28(4):174-8. PubMed ID: 8853283 [TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and depot medroxyprogesterone acetate. Albertazzi P; Bottazzi M; Steel SA Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487 [TBL] [Abstract][Full Text] [Related]
14. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705 [TBL] [Abstract][Full Text] [Related]
15. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women. Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439 [TBL] [Abstract][Full Text] [Related]
16. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: results after six months. Grossman RA; Assawasena V; Chalpati S; Taewtong D Bull World Health Organ; 1977; 55(1):67-78. PubMed ID: 302157 [TBL] [Abstract][Full Text] [Related]
17. Counseling issues and management of side effects for women using depot medroxyprogesterone acetate contraception. Nelson AL J Reprod Med; 1996 May; 41(5 Suppl):391-400. PubMed ID: 8725701 [TBL] [Abstract][Full Text] [Related]
18. Galactorrhea in DMPA users: incidence and clinical significance. Gongsakdi D; Rojanasakul A J Med Assoc Thai; 1986 Jan; 69(1):28-32. PubMed ID: 2937870 [TBL] [Abstract][Full Text] [Related]
19. Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate. Huovinen K; Tikkanen MJ; Autio S; Härkönen T; Lommi L; Varonen S; Wilska ML Acta Obstet Gynecol Scand; 1991; 70(4-5):349-54. PubMed ID: 1836088 [TBL] [Abstract][Full Text] [Related]
20. Depot-medroxyprogesterone acetate in anticoagulated patients with previous hemorrhagic corpus luteum. Sönmezer M; Atabekoğlu C; Cengiz B; Dökmeci F; Cengiz SD Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):9-14. PubMed ID: 16036292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]